$アラコス(ALLK.US)$Allakos | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.8%) SEC announcement · 01/29 17:30
1
1
報告
JCBFスレ主 :
Allakos | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-I.R.S. IDENTIFICATION NO. John P. McKearn, Ph.D.(0.2%),I.R.S. IDENTIFICATION NO. Thomas C. Melzer(0.03%)
$アラコス(ALLK.US)$Allakos Announced Topline Data From Its Phase 2 Trial For Lirentelimab In Atopic Dermatitis (ATLAS) And Phase 2B Study In Chronic Spontaneous Urticaria (MAVERICK); The Studies Did Not Meet Their Primary Endpoints
Allakos' 57% reduction in cash burn exhibits resilience, yet it's a high-risk stock due to large cash burn in comparison to market value. Future growth funding may cause substantial share dilution. The firm's ability to secure more funds and its future business growth are key considerations.
アラコスに関するコメント
still think it will be heading back to price gap
SEC announcement
·
01/29 17:30
interesting
Holly S plunged
TIMBER!
Upcoming Ph 2 readouts in Q1 2024…
$リジェネックスバイオ(RGNX.US)$ Phase 2
$リープ・セラピューティクス(LPTX.US)$ Phase 2
$4Dモレキュラー・セラピューティクス(FDMT.US)$ Phase 2
$アドベラム・バイオテクノロジーズ(ADVM.US)$ Phase 2
$デナリ・セラピューティクス(DNLI.US)$ Phase 2
$アイポイント・ファーマシューティカルズ(EYPT.US)$ Phase 2
$ゼンコー(XNCR.US)$ Phase 2
$ハーモニー・バイオサイエンシーズ(HRMY.US)$ Phase 2
$アルナイラム・ファーマシューティカルズ(ALNY.US)$ Phase 2
$ディスク・メディシン(IRON.US)$ Phase 2
$アテア・ファーマシューティカルズ(AVIR.US)$ Phase 2
$アラコス(ALLK.US)$ Phase 2...
Current watch ⚡️
👀
まだコメントはありません